Valuation: OrthoPediatrics Corp.

Market Cap 685M 586M 547M 502M 943M 65.53B 962M 6.49B 2.53B 32.84B 2.57B 2.52B 109B P/E 2026 *
-21.5x
P/E 2027 * -32.2x
Enterprise Value 685M 586M 547M 502M 943M 65.53B 962M 6.49B 2.53B 32.84B 2.57B 2.52B 109B EV / Sales 2026 *
2.57x
EV / Sales 2027 * 2.29x
Free-Float
67.68%
Yield 2026 *
-
Yield 2027 * -
1 day-1.02%
1 week+4.88%
Current month+29.92%
1 month+34.38%
3 months+41.78%
6 months+54.66%
Current year+47.69%
1 week 24.32
Extreme 24.325
26.74
1 month 18.1
Extreme 18.1
26.74
Current year 14.42
Extreme 14.42
26.74
1 year 14.42
Extreme 14.42
26.74
3 years 14.42
Extreme 14.42
38.99
5 years 14.42
Extreme 14.42
73.91
10 years 14
Extreme 14.0001
73.91
Manager TitleAgeSince
Chief Executive Officer 47 03/06/2021
Director of Finance/CFO 58 01/02/2015
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Director/Board Member 47 03/11/2021
Chairman 75 03/06/2021
Director/Board Member 70 01/01/2011
Date Insider Type Main position Quantity % Market Cap.
29/12/25 Don

Chief Executive Officer

1,600 0.0064%
10/11/25 Free

Director

4,345 0.0173%
10/11/25 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-1.02%+4.88%+34.65%-31.73% 685M
-3.61%-3.93%-16.38%+17.92% 126B
-1.91%-3.88%-23.94%-1.50% 12.32B
-2.46%-2.41%+103.31%+157.51% 10.9B
+2.99%-6.01%-48.48%-68.43% 4.35B
+1.60%-1.88%-24.39%+48.84% 2.7B
-0.68%+5.27%-34.15%-71.70% 1.77B
+3.02%-0.62%-22.25%-12.11% 1.68B
+4.84%-0.01%-33.39%-34.24% 1.67B
Average +0.31%-0.32%-7.22%+0.51% 17.97B
Weighted average by Cap. -2.94%-3.46%-10.10%+21.99%

Financials

2026 *2027 *
Net sales 267M 229M 213M 196M 368M 25.55B 375M 2.53B 986M 12.8B 1B 981M 42.39B 299M 256M 239M 219M 412M 28.59B 420M 2.83B 1.1B 14.33B 1.12B 1.1B 47.44B
Net income -28.77M -24.64M -22.99M -21.09M -39.63M -2.75B -40.41M -273M -106M -1.38B -108M -106M -4.57B -18.48M -15.82M -14.76M -13.55M -25.45M -1.77B -25.96M -175M -68.27M -886M -69.39M -67.88M -2.93B
Net Debt - -
Logo OrthoPediatrics Corp.
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
Employees
602
Date Price Change Volume
20/08/26 USD 26.23 -1.02% 259,617
19/08/26 USD 26.50 +3.92% 378,005
18/08/26 USD 25.50 +3.24% 206,276
17/08/26 USD 24.70 -0.40% 177,326
14/08/26 USD 24.80 -0.84% 132,779
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
26.23USD
Average target price
27.22USD
Spread / Average Target
+3.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KIDS Stock